Clinicopathological features, diagnosis, and treatment of sessile serrated adenoma/polyp with dysplasia/carcinoma
- PMID: 31158302
- DOI: 10.1111/jgh.14752
Clinicopathological features, diagnosis, and treatment of sessile serrated adenoma/polyp with dysplasia/carcinoma
Abstract
Sessile serrated adenoma/polyps (SSA/Ps) are early precursor lesions in the serrated neoplasia pathway, which results in BRAF-mutated colorectal carcinomas with not only high levels of microsatellite instability but also microsatellite stable. SSA/Ps with advanced histology, including cytological dysplasia or minimally invasive carcinomas, are important lesions because SSA/Ps are considered major contributors to "interval cancers" and these lesions can rapidly become dysplastic or invasive carcinomas. Clinicopathologically, SSA/Ps with dysplasia or invasive carcinoma were associated with advanced age, female sex, and proximal colon. Although SSA/Ps with submucosal invasive carcinoma were smaller and invaded less deeply into the submucosal layer than conventional tubular adenomas with submucosal invasive carcinoma, SSA/Ps with submucosal invasive carcinoma frequently had a mucinous component and exhibited a higher potential for lymphatic invasion and lymph node metastasis. In an SSA/P series, endoscopic characteristics, including (semi)pedunculated morphology, double elevation, central depression, and reddishness, may help accurately diagnose SSA/Ps with advanced histology. Removal of SSA/Ps with dysplasia or invasive carcinoma was recommended. Endoscopic treatment such as endoscopic mucosal resection or endoscopic submucosal dissection is useful for those lesions. However, surgical resection with lymph node dissection might be indicated when SSA/Ps with invasive carcinoma are endoscopically suspected, because these have the high risk of lymph node metastasis. Greater awareness may promote further research into improving the detection, recognition, and complete resection rates of SSA/Ps with dysplasia or invasive carcinoma and reduce the interval cancer rates.
Keywords: Carcinoma arising in sessile serrated adenoma/polyp; Endoscopic diagnosis; Endoscopic therapy; Serrated neoplasia pathway; Sessile serrated adenoma/polyp; Sessile serrated adenoma/polyp with cytological dysplasia.
© 2019 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
Comment in
-
Sessile serrated adenoma/polyps: Why we should be working flat out to understand more about these flat lesions?J Gastroenterol Hepatol. 2019 Oct;34(10):1667-1668. doi: 10.1111/jgh.14891. J Gastroenterol Hepatol. 2019. PMID: 31726488 No abstract available.
Similar articles
-
Endoscopic diagnosis of sessile serrated adenoma/polyp with and without dysplasia/carcinoma.World J Gastroenterol. 2018 Aug 7;24(29):3250-3259. doi: 10.3748/wjg.v24.i29.3250. World J Gastroenterol. 2018. PMID: 30090005 Free PMC article. Review.
-
Distinct endoscopic characteristics of sessile serrated adenoma/polyp with and without dysplasia/carcinoma.Gastrointest Endosc. 2017 Mar;85(3):590-600. doi: 10.1016/j.gie.2016.09.018. Epub 2016 Sep 20. Gastrointest Endosc. 2017. PMID: 27663716
-
Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study.Diagn Pathol. 2018 Nov 20;13(1):88. doi: 10.1186/s13000-018-0771-3. Diagn Pathol. 2018. PMID: 30458818 Free PMC article.
-
Distinct histopathological characteristics in colorectal submucosal invasive carcinoma arising in sessile serrated adenoma/polyp and conventional tubular adenoma.Virchows Arch. 2018 Mar;472(3):383-393. doi: 10.1007/s00428-017-2234-8. Epub 2017 Sep 19. Virchows Arch. 2018. PMID: 28929387
-
Sessile serrated lesions: Clinicopathological characteristics, endoscopic diagnosis, and management.Dig Endosc. 2022 Sep;34(6):1096-1109. doi: 10.1111/den.14273. Epub 2022 Mar 29. Dig Endosc. 2022. PMID: 35352394 Review.
Cited by
-
Clinical and endoscopic characteristics of sessile serrated lesions with dysplasia/carcinoma.Korean J Intern Med. 2023 May;38(3):349-361. doi: 10.3904/kjim.2022.322. Epub 2023 Mar 27. Korean J Intern Med. 2023. PMID: 36967594 Free PMC article.
-
Sessile serrated lesions with dysplasia: is it possible to nip them in the bud?J Gastroenterol. 2023 Aug;58(8):705-717. doi: 10.1007/s00535-023-02003-9. Epub 2023 May 23. J Gastroenterol. 2023. PMID: 37219625 Free PMC article. Review.
-
Identifying the tumor location-associated candidate genes in development of new drugs for colorectal cancer using machine-learning-based approach.Med Biol Eng Comput. 2022 Oct;60(10):2877-2897. doi: 10.1007/s11517-022-02641-w. Epub 2022 Aug 10. Med Biol Eng Comput. 2022. PMID: 35948841
-
1L NER1006 can improve rates of adequate and high-quality bowel cleansing in the right colon: a post hoc analysis of two randomised clinical trials.BMC Gastroenterol. 2022 Jan 25;22(1):35. doi: 10.1186/s12876-022-02106-2. BMC Gastroenterol. 2022. PMID: 35078404 Free PMC article. Clinical Trial.
-
Transcolonic endoscopic appendectomy: a novel natural orifice transluminal endoscopic surgery (NOTES) technique for the sessile serrated lesions involving the appendiceal orifice.Gut. 2021 Oct;70(10):1812-1814. doi: 10.1136/gutjnl-2020-323018. Epub 2021 Jan 22. Gut. 2021. PMID: 33483328 Free PMC article. No abstract available.
References
-
- Torlakovic E, Skovlund E, Snover DC, Torlakovic G, Nesland JM. Morphologic reappraisal of serrated colorectal polyps. Am. J. Surg. Pathol. 2003; 27: 65-81.
-
- Snover DC, Ahnen DJ, Burt RW. Serrated polyps of the colon and rectum and serrated polyposis. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, eds. WHO Classification of Tumours of the Digestive System. Lyon: IARC Press, 2010; 160-165.
-
- Kambara T, Simms LA, Whitehall VL et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 2004; 53: 1137-1144.
-
- O'Brien MJ, Yang S, Mack C et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am. J. Surg. Pathol. 2006; 30: 1491-1501.
-
- Patil DT, Shadrach BL, Rybicki LA, Leach BH, Pai RK. Proximal colon cancers and the serrated pathway: a systematic analysis of precursor histology and BRAF mutation status. Mod. Pathol. 2012; 25: 1423-1431.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials